Paul M. Silva
2019
In 2019, Paul M. Silva earned a total compensation of $3.2M as SVP & Corporate Controller at Vertex Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $378,000 |
|---|---|
| Option Awards | $468,803 |
| Salary | $442,569 |
| Stock Awards | $1,895,084 |
| Other | $13,401 |
| Total | $3,197,857 |
Silva received $1.9M in stock awards, accounting for 59% of the total pay in 2019.
Silva also received $378K in non-equity incentive plan, $468.8K in option awards, $442.6K in salary and $13.4K in other compensation.
Rankings
In 2019, Paul M. Silva's compensation ranked 3,818th out of 13,971 executives tracked by ExecPay. In other words, Silva earned more than 72.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,818 out of 13,971 | 73rd |
Division Manufacturing | 1,382 out of 5,692 | 76th |
Major group Chemicals And Allied Products | 485 out of 2,189 | 78th |
Industry group Drugs | 409 out of 1,875 | 78th |
Industry Pharmaceutical Preparations | 310 out of 1,387 | 78th |
Source: SEC filing on April 28, 2020.
Silva's colleagues
We found six more compensation records of executives who worked with Paul M. Silva at Vertex Pharmaceuticals in 2019.
2019
Jeffrey Leiden
Vertex Pharmaceuticals
Chairman
2019
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2019
Reshma Kewalramani
Vertex Pharmaceuticals
Chief Executive Officer
2019
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Patient Officer
2019
Charles Wagner
Vertex Pharmaceuticals
Chief Financial Officer
2019
Ian Smith
Vertex Pharmaceuticals